Buy or sell Medable stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Medable Stock

Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.

About Medable Stock

Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. It is now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages. It was founded in 2015 and is headquartered in Palo Alto, California.

Funding History

January 2012$928K
February 2017$3.9M
April 2020$28.6M
April 2020$17.6M
October 2020$96.2M
April 2021$78.9M
September 2021$305M

Management

Co-Founder & Chief Architect

James Sas

Co-Founder & CEO

Michelle Longmire

Co-Founder & CTO

Tim Smith

Director of Mobile Development

Fernando Waigandt

Chief Design Officer

Sina Mossayeb

Chief Growth Officer

Sanskriti Thakur

CFO

Jason Sauvie

VP Partner Strategy

Steve Lesser

Senior Vice President, Engineering

Michael Deerkoski

SVP, Strategy and Solutions

Ching Tian

EVP Sales

Eric M. Peper

VP User Experience

Andrew Purcell

General Counsel, Secretary & Chief Compliance Officer

Perry Robinson

VP Customer Success

Jared Klingeisen

VP Product Management

Niraj Patel

Board Observer

Cathy Gao

Chief Product Officer

Parag Vaish

Senior VP of Marketing

David Swanger

VP Legal & SaMD

Andrea Sanchez

Head of Decentralised Clinical Trials

Alison Holland

VP Mobile Development

Hernan Pelassini

Head of Commercial and Strategic Partnerships

Gillian Livock

Board Member

Sunny Kumar

DevOps Tech Lead

Jacobi Petrucciani

VP Life Sciences

Tyler Pugsley

Board Member

David Hartwig

Director of Product Marketing

Douglas Weatherhead

VP of AI/ML

Gabor Melli

Chief Scientific Officer

Pamela Tenaerts

SVP Research & Academics

Ingrid Oakley-Girvan

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo